SCHEMBL7298922

SCHEMBL7298922

CC(C)OC(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.47
KLK5 Q9Y337 2/20 0.45
CYP3A4 P08684 3/20 0.44
CTRB1 P17538 2/20 0.44
PSEN1 P49768 3/20 0.43
PSEN2 P49810 3/20 0.43
APH1B Q8WW43 3/20 0.43
NCSTN Q92542 3/20 0.43
APH1A Q96BI3 3/20 0.43
PSENEN Q9NZ42 3/20 0.43
APP P05067 1/20 0.43
MAPK1 P28482 1/20 0.43
ATM Q13315 1/20 0.43
TSHR P16473 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HTT P42858 1/20 0.42
ABCC3 O15438 1/20 0.41
ABCC4 O15439 1/20 0.41
ABCB11 O95342 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7310283 0.85 CTRB1 (0.48) CA2KLK5CYP3A4CTRB1PSEN1
SCHEMBL8490932 0.84 HTT (0.47) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL8490546 0.84 HTT (0.47) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL8486300 0.84 TSHR (0.49) KLK5CTRB1TSHRNPC1RAB9A
SCHEMBL7270247 0.84 ATM (0.62) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL7301095 0.84 ATM (0.62) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL7305946 0.84 ATM (0.62) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL7299571 0.84 ATM (0.62) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL893605 0.83 CYP3A4 (0.61) CYP3A4MAPK1ABCC3ABCC4ABCB11
SCHEMBL7302263 0.83 CYP1A2 (0.45) CA2KLK5CYP3A4CTRB1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed